Commercialization & Communication Through the Clinical Experience in the Rare & Genetic Kidney Disease Space
Time: 2:01 pm
day: Workshop F
Details:
- Discussing pricing, reimbursement and market access in the context of standard of care and prescriber burden
- Understanding payer concerns around rare disease coverage for therapeutic interventions
- Communicating the clinical value of orphan drugs in the rare and genetic kidney disease setting to a breadth of stakeholders
- Outlining stories of value demonstration to private insurers to incentivise prescription and enrolment
